This image displays the anticipated urinary colour change following administration of hydroxocobalamin, which is benign and self-limited but may make intermittent hemodialysis difficult
Zhou N, Hofstetter WL, Mitchell KG, Bayley EM, Ajani JA, Antonoff MB, Betancourt SL, Blum-Murphy M, Feldman HA, Lin SH, Maru DM, Mehran RJ, Rajaram R, Rice DC , Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Weston BR
Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M, et al
Convenient capsule format designed for consistent daily use
Our IHPC treatment pattern was as follows: mice were treated with 10 cycles of intermittent hypoxia per day